In this report, Forte’s Director of Analytics Wendy Tate identifies key data trends that are impacting research centers today. Using Forte Benchmarks, an award-winning comparative analytics tool, this report analyzes aggregate data from over 28 research organizations nationwide.
This case study tells the story of how EVAL helped UW Carbone Cancer Center receive a unanimous “Outstanding” grade on their CCSG renewal.
Applying for the Cancer Center Support Grant (CCSG) is a difficult process to manage, especially for centers applying for the first time when seeking NCI-designation. The CCSG application process is complex and resource-intensive, especially when data is decentralized, and processes are not clearly defined. This is the story of how the University of Florida Health…
In this report, Forte’s Director of Analytics Wendy Tate identifies key data trends that are impacting cancer centers today. Using Forte Benchmarks, an award-winning comparative analytics tool, this report analyzes aggregate data from over 20 cancer centers nationwide.
Clinical research organizations must continuously evaluate their clinical trial practices to keep up with new industry challenges. Avoid these common mistakes when building an analytics strategy for your operational performance.
With many advancements in tools and technologies, research organizations can gain deep insights into clinical research performance. If you experience these challenges, Business Intelligence can help provide proactive, strategic insights.
Learn the value of a community-driven approach to clinical research analytics solutions.
Strategies to help convince leadership to invest in a business intelligence solution to optimize operations and inform strategic decision-making.